This inventor holds 4 USPTO granted patents and 5 published patent applications and 3 EPO patents. Top assignee: Molecular Templates, Inc.. Active years: 2022-2026.
Company Filing History:
Years Active: 2022-2026
Title: Garrett Lee Robinson: Innovator in Therapeutic Technologies
Introduction
Garrett Lee Robinson is a prominent inventor based in Austin, TX (US). He has made significant contributions to the field of therapeutic technologies, holding a total of 4 patents. His work focuses on developing innovative solutions for medical applications, particularly in the realm of immunology and targeted therapies.
Latest Patents
Robinson's latest patents include groundbreaking inventions such as "De-immunized Shiga toxin a subunit effector polypeptides for applications in mammals." This invention addresses the limitations of immunogenicity in the administration of proteins derived from Shiga toxins. The Shiga toxin effector polypeptides developed by Robinson have potential applications in therapeutics, diagnostics, and immunization materials. They can selectively target and kill specific cell types, offering new avenues for treating diseases like cancers, immune disorders, and microbial infections.
Another notable patent is "Cell-targeting molecules comprising de-immunized, Shiga toxin a subunit effectors and CD8+ T-cell epitopes." This invention provides a method for delivering CD8+ T-cell epitope cargo to the MHC class I presentation pathway of target cells. The cell-targeting molecules can be utilized to label and kill specific cell types, including malignant and non-immune cells. This technology has promising applications in treating various diseases, including cancers and immune disorders.
Career Highlights
Garrett Lee Robinson is currently associated with Molecular Templates, Inc., where he continues to advance his research and development efforts. His innovative work has positioned him as a key player in the field of therapeutic technologies.
Collaborations
Robinson collaborates with notable colleagues, including Eric Poma and Erin Willert, who contribute to the advancement of their shared goals in medical innovation.
Conclusion
Garrett Lee Robinson's contributions to therapeutic technologies through his patents demonstrate his commitment to improving medical treatments and patient outcomes. His innovative approaches have the potential to revolutionize the way diseases are treated and managed.